Thus, due to the positive effects of adiponectin on insulin sensitivity and metabolic syndrome, it seems that TG lowering agents can be used as therapeutic options in improving the insulin sensitivity of diabetic patients. The gene discussed is ADIPOQ; the disease is metabolic syndrome.